PR-104A
PR-104A is a hypoxia-activated prodrug designed for anticancer research. It is metabolized under low-oxygen conditions to release cytotoxic DNA cross-linking agents, enabling the study of hypoxic tumor targeting in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
680199-06-8
Field of Research
Metabolism Research, Molecular Biology
Smiles
CS (=O) (=O) OCCN (CCBr) c1c (cc (cc1[N+] ([O-]) =O) [N+] ([O-]) =O) C (=O) NCCO
Molecular Formula
C14H19BrN4O9S
Molecular Weight
499.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1455116 Inquire
Recombinant Human Liprin-beta-2 (PPFIBP2) , partial
Sign In for Pricing
View Details 
CSB-YP382675BO-01 20 µg
Recombinant Bovine Serpin A3-5 (SERPINA3-5)
Sign In for Pricing
View Details CSB-YP382675BO-02 100 µg
Recombinant Bovine Serpin A3-5 (SERPINA3-5)
Sign In for Pricing
View Details 
NBP3-20726AF750 0.1 mL
Mouse Monoclonal Cytokeratin 14 Antibody (rKRT14/8692) [Alexa Fluor 750]
Sign In for Pricing
View Details